High-dose rate interstitial with external beam irradiation for localized prostate cancer - Results of a prospective trial

Radiotherapy and Oncology

Volumn 48, Issue 2, 1998, Pages 197-202

  Dinges, Stefan ^a   Deger, Sedar ^a   Koswig, Stephan ^a   Boehmer, Dirk ^a   Schnorr, Dietmar ^a   Wiegel, Thomas ^b   Loening, Stefan August ^a   Dietel, Manfred ^a   Hinkelbein, Wolfgang ^b   Budach, Volker ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

High dose rate interstitial with external beam irradiation; Localized prostate cancer; Prospective trial

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; COLOSTOMY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INTERSTITIAL RADIATION; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RADIATION DOSE; RISK ASSESSMENT; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; BIOPSY; BRACHYTHERAPY; COLITIS, ULCERATIVE; COLOSTOMY; DIABETES COMPLICATIONS; FEASIBILITY STUDIES; FISTULA; FOLLOW-UP STUDIES; HUMANS; IRIDIUM RADIOISOTOPES; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RECTAL FISTULA; RISK FACTORS; URETHRAL DISEASES;

EID: 0031665297     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(98)00054-1     Document Type: Article

References (28)

1. American Joint Committee on Cancer. Manual for Staging of Cancer, 4th edn., p. 181. J.B. Lippincott, Philadelphia, PA, 1992.
2. Cox, D.R. and Oakes, D. Analysis of Survival Data. Chapman and Hall, London, 1984.
3. Hanks, G.E. Treatment of early stage prostate cancer: radiotherapy. Important Adv. Oncol. 3: 225-239, 1994.
4. Hanks, G.E., Martz, K.L. and Diamond, J.J. The effect of dose on local control of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 15: 1299-1305, 1988.
5. Hanks, G.E., Schultheiss, T.E., Hunt, M.A. and Epstein, B. Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 31: 25-29, 1995.
6. International Commission on Radiation Units and Measurements. ICRU Report No. 50 - Prescribing, Recording, and Reporting Photon Beam Therapy. ICRU, Bethesda, MD, 1993.
7. Kaplan, E. and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53: 457-481, 1958.
8. Khan, K., Thompson, W., Bush, S. and Stidley, C. Transperineal percutaneous iridium-192 interstitial template implant of the prostate: results and complications in 321 patients. Int. J. Radiat. Oncol. Biol. Phys. 22: 935-939, 1992.
9. Klein, F.A., Ali, M.M., Marks, S.E. and Hackler, R.H. Bilateral pelvic lymphadenectomy, iridium 192 template, and external beam therapy for localized prostatic carcinoma: complications and results. South Med. J. 81: 27-31, 1988.
10. Kovacs, G., Wirth, B., Bertermann, H., et al. Prostate preservation by combined external beam and HDR brachytherapy at node negative prostate cancer patients - an intermediate analysis after 10 years experience. Int. J. Radiat. Oncol. Biol. Phys. 36: 198, 1996.
11. Laverdiere, J., Gomez, J.L., Cusan, L., et al. Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 37: 247-252, 1997.
12. Lee, W.R., Hanks, G.E., Schultheiss, T.E., Corn, B.W. and Hunt, M.A. Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen-driven outcome analysis. J. Clin. Oncol. 13: 464-469, 1995.
13. Leibel, S.A., Zelefsky, M.J., Kutcher, G.J., Burman, C.M., Kelson, S. and Fuks, Z. Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: interim report of a phase 1 dose-escalation study. J. Urol. 152: 1792-1798, 1994.
14. Marinelli, D., Shanberg, A.M., Tansey, L.A., Sawyer, D.E., Syed, N. and Puthawala, A. Follow-up prostate biopsy in patients with carcinoma of the prostate treated by 192iridium template irradiation plus supplemental external beam radiation. J. Urol. 147: 922-925, 1992.
15. Martinez, A., Gonzalez, J., Stromberg, J., et al. Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial. Int. J. Radiat. Oncol. Biol. Phys. 33: 1019-1027, 1995.
16. Morton, R.A., Steiner, M.S. and Walsh, P.C. Cancer control follow-ing anatomical radical prostatectomy: an interim report. J. Urol. 145: 1197-1200, 1991.
17. Pilepich, M.V. Radiation Therapy Oncology Group studies in carcinoma of the prostate. Natl. Cancer Inst. Monogr. 17: 61-65, 1988.
18. Pilepich, M.V., Krall, J.M., al Sarraf, M., et al. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology 45: 616-623, 1995.
19. Schuessler, W.W., Vancaillie, T.G., Reich, H. and Griffith, D.P. Transperitoneal endosurgical lymphadenectomy in patients with localized prostate cancer. J. Urol. 145: 988-991, 1991.
20. Schultheiss, T.E., Lee, W.R. and Hanks, G.E. Lokal fortgeschrittenes Prostatakarzinom/locally advanced prostate cancer T3/C. 1. In: Analysis of Acute and Late Morbidity in Conformal and Standard Radiation Treatment of Prostate Cancer, pp. 203-216. Editors: D. Schnorr, S.A. Loening, S. Dinges and V. Budach. Blackwell, Berlin, 1995.
21. Schwarzer, J.U., Hoffmann, R., Kneschaurek, P., Lukas, P., Lindner, A. and Braun, J. High-dose-rate brachytherapy of prostatic carcinoma with iridium 192. Strahlenther. Onkol. 168: 17-22, 1992.
22. Smit, W.G., Helle, P.A., van Putten, W.L., Wijnmaalen, A.J., Seldenrath, J.J. and van der Werf Messing, B.H. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. Int. J. Radiat. Oncol. Biol. Phys. 18: 23-29, 1990.
23. Sommerkamp, H. and Slanina, J. Kombinierte Strahlen- und Hormontherapie des Prostatakarzinoms: eine Konzeptanalyse. Strahlenther. Onkol. 167: 523-529, 1991.
24. Stromberg, J., Martinez, A., Benson, R., et al. Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation. Int. J. Radiat. Oncol. Biol. Phys. 28: 67-75, 1994.
25. Stromberg, J., Martinez, A., Gonzalez, J., et al. Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I/II clinical trial. Int. J. Radiat. Oncol. Biol. Phys. 33: 161-171, 1995.
26. Syed, A.M., Puthawala, A., Austin, P., et al. Temporary iridium-192 implant in the management of carcinoma of the prostate. Cancer 69: 2515-2524, 1992.
27. Zietman, A.L., Coen, J.J., Dallow, K.C. and Shipley, W.U. The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome (see comments). Int. J. Radiat. Oncol. Biol. Phys. 32: 287-292, 1995.
28. Zietman, A.L., Shipley, W.U. and Willett, C.G. Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications. Cancer 71: 959-969, 1993.